Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201 Biotech Investing
Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection Pharmaceutical Investing
Isodiol International Inc. Launches ISOCare, an Innovative Platform for the Cannabis Treatment Industry Cannabis Investing News
Naturally Splendid Announces Purchase Order for National Distribution Bar Line Cannabis Investing News
Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer Biotech Investing
PreveCeutical Signs Agreement with Asterion Cannabis Inc. to License Natural Health Products and Engages Monster Media, LLC to Provide Investor Relations Services Cannabis Investing News
Isodiol International Inc. Announces Former IFBB Professional Bodybuilder, David Hawk, Joins Iso-Sport Management Team Cannabis Investing News
